{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:43:13Z","timestamp":1783035793020,"version":"3.54.6"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The norepinephrine transporter (NET) is a major target for the evaluation of the cardiac sympathetic nerve system in patients with heart failure and Parkinson's disease. It is also used in the therapeutic applications against certain types of neuroendocrine tumors, as exemplified by the clinically used <jats:sup>123\/131<\/jats:sup>I-MIBG as theranostic single-photon emission computed tomography (SPECT) agent. With the development of more advanced positron emission tomography (PET) technology, more radiotracers targeting NET have been reported, with superior temporal and spatial resolutions, along with the possibility of functional and kinetic analysis. More recently, fluorine-18-labelled NET tracers have drawn increasing attentions from researchers, due to their longer radiological half-life relative to carbon-11 (110\u00a0min vs. 20\u00a0min), reduced dependence on on-site cyclotrons, and flexibility in the design of novel tracer structures. In the heart, certain NET tracers provide integral diagnostic information on sympathetic innervation and the nerve status. In the central nervous system, such radiotracers can reveal NET distribution and density in pathological conditions. Most radiotracers targeting cardiac NET-function for the cardiac application consistent of derivatives of either norepinephrine or MIBG with its benzylguanidine core structure, e.g. <jats:sup>11<\/jats:sup>C-HED and <jats:sup>18<\/jats:sup>F-LMI1195. In contrast, all NET tracers used in central nervous system applications are derived from clinically used antidepressants. Lastly, possible applications of NET as selective tracers over organic cation transporters (OCTs) in the kidneys and other organs controlled by sympathetic nervous system will also be discussed.<\/jats:p>","DOI":"10.1007\/s00702-020-02180-4","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T15:03:46Z","timestamp":1586444626000},"page":"851-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements"],"prefix":"10.1007","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-1689","authenticated-orcid":false,"given":"Xinyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8484-9209","authenticated-orcid":false,"given":"Takashi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-2207","authenticated-orcid":false,"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-0613","authenticated-orcid":false,"given":"Andreas","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-7835","authenticated-orcid":false,"given":"Takahiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"issue":"1091","key":"2180_CR1","doi-asserted-by":"crossref","first-page":"20180103","DOI":"10.1259\/bjr.20180103","volume":"91","author":"A Agrawal","year":"2018","unstructured":"Agrawal A, Rangarajan V, Shah S, Puranik A, Purandare N (2018) MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies. Br J Radiol 91(1091):20180103","journal-title":"Br J Radiol"},{"issue":"11","key":"2180_CR2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00259-017-3760-y","volume":"44","author":"T Aikawa","year":"2017","unstructured":"Aikawa T, Naya M, Obara M, Oyama-Manabe N, Manabe O, Magota K et al (2017) Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: 11C-hydroxyephedrine PET study. Eur J Nucl Med Mol Imaging 44(11):1897\u20131905","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"2180_CR3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2967\/jnumed.108.051292","volume":"49","author":"R Arakawa","year":"2008","unstructured":"Arakawa R, Okumura M, Ito H, Seki C, Takahashi H, Takano H et al (2008) Quantitative analysis of norepinephrine transporter in the human brain using PET with (S, S)-18F-FMeNER-D2. J Nucl Med 49(8):1270\u20131276","journal-title":"J Nucl Med"},{"issue":"4","key":"2180_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ijnp\/pyz003","volume":"22","author":"R Arakawa","year":"2019","unstructured":"Arakawa R, Stenkrona P, Takano A, Svensson J, Andersson M, Nag S et al (2019a) Venlafaxine ER blocks the norepinephrine transporter in the brain of patients with major depressive disorder: a PET study using [18F]FMeNER-D2. Int J Neuropsychopharmacol 22(4):278\u2013285","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"2180_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ijnp\/pyy089","volume":"22","author":"R Arakawa","year":"2019","unstructured":"Arakawa R, Takano A, Halldin C (2019b) Serotonin and norepinephrine transporter occupancy of tramadol in nonhuman primate using positron emission tomography. Int J Neuropsycholpharmacol 22(1):53\u201356","journal-title":"Int J Neuropsycholpharmacol"},{"issue":"3","key":"2180_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2008.12.010","volume":"36","author":"M Bayer","year":"2009","unstructured":"Bayer M, Ku\u00e7i Z, Sch\u00f6mig E, Gr\u00fcndemann D, Dittmann H, Handgretinger R, Bruchelt G (2009) Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells. Nucl Med Biol 36(3):287\u2013294","journal-title":"Nucl Med Biol"},{"issue":"9","key":"2180_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nucmedbio.2016.05.013","volume":"43","author":"M Bayer","year":"2016","unstructured":"Bayer M, Schmitt J, Dittmann H, Handgretinger R, Bruchelt G, Sauter AW (2016) Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids. Nucl Med Biol 43(9):543\u2013551","journal-title":"Nucl Med Biol"},{"issue":"6","key":"2180_CR8","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1210\/jc.2017-02717","volume":"103","author":"R Belfort-DeAguiar","year":"2018","unstructured":"Belfort-DeAguiar R, Gallezot JD, Hwang JJ, Elshafie A, Yeckel CW, Chan O, Carson RE, Ding YS, Sherwin RS (2018) Noradrenergic activity in the human brain: a mechanism supporting the defense against hypoglycemia. J Clin Endocrinol Metab 103(6):2244\u20132252","journal-title":"J Clin Endocrinol Metab"},{"key":"2180_CR9","volume-title":"Basic and clinical pharmacology","author":"I Biaggioni","year":"2012","unstructured":"Biaggioni I, Robertson D (2012) Adrenoceptor agonists & sympathomimetic drugs (Chapter 9). In: Katzung B, Masters SB, Trevor AJ (eds) Basic and clinical pharmacology. McGraw-Hill, New York"},{"key":"2180_CR10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/3-540-29784-7_20","volume":"175","author":"H B\u00f6nisch","year":"2006","unstructured":"B\u00f6nisch H, Br\u00fcss M (2006) The norepinephrine transporter in physiology and disease. Handb Exp Pharmacol 175:485\u2013524","journal-title":"Handb Exp Pharmacol"},{"key":"2180_CR11","doi-asserted-by":"publisher","first-page":"6031478","DOI":"10.1155\/2017\/6031478","volume":"2017","author":"O Borodovitsyna","year":"2017","unstructured":"Borodovitsyna O, Flamini M, Chandler D (2017) Noradrenergic modulation of cognition in health and disease. Neural Plast 2017:6031478. https:\/\/doi.org\/10.1155\/2017\/6031478","journal-title":"Neural Plast"},{"issue":"2","key":"2180_CR12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/eat.22621","volume":"50","author":"A Bresch","year":"2017","unstructured":"Bresch A, Rullmann M, Luthardt J, Becker GA, Reissig G, Patt M et al (2017) Emotional eating and in vivo norepinephrine transporter availability in obesity: a [11C]MRB PET pilot study. Int J Eat Disord 50(2):152\u2013156","journal-title":"Int J Eat Disord"},{"issue":"2","key":"2180_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12149-018-1305-5","volume":"33","author":"J Brumberg","year":"2019","unstructured":"Brumberg J, Tran-Gia J, Lapa C, Isaias IU, Samnick S (2019) PET imaging of noradrenaline transporters in Parkinson's disease: focus on scan time. Ann Nucl Med 33(2):69\u201377","journal-title":"Ann Nucl Med"},{"issue":"11","key":"2180_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FPC.0b013e32833fe789","volume":"20","author":"L Chen","year":"2010","unstructured":"Chen L, Pawlikowski B, Schlessinger A, More SS, Stryke D, Johns SJ et al (2010) Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. Pharmacognenet Genomics 20(11):687\u2013699","journal-title":"Pharmacognenet Genomics"},{"key":"2180_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-019-01407-5","author":"X Chen","year":"2019","unstructured":"Chen X, Fritz A, Werner RA, Nose N, Yagi Y, Kimura H, Rowe SP, Koshino K, Decker M, Higuchi T (2019) Initial evaluation of AF78: a rationally designed fluorine-18-Labelled PET radiotracer targeting norepinephrine transporter. Mol Imaging Biol. https:\/\/doi.org\/10.1007\/s11307-019-01407-5","journal-title":"Mol Imaging Biol"},{"key":"2180_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13550-018-0365-9","volume":"8","author":"X Chen","year":"2018","unstructured":"Chen X, Werner RA, Lapa C, Hirano M, Javadi MS, Robinson S, Higuchi T (2018) Subcellular storage and release mode of the novel 18F-labeled sympathetic nerve PET tracer LMI1195. EJNMMI Res 8:12","journal-title":"EJNMMI Res"},{"issue":"2","key":"2180_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-0270(97)00094-0","volume":"76","author":"P Deep","year":"1997","unstructured":"Deep P, Gjedde A, Cumming P (1997) On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo. J Neurosci Methods 76(2):157\u2013165","journal-title":"J Neurosci Methods"},{"key":"2180_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","volume":"5","author":"C Delaville","year":"2011","unstructured":"Delaville C, De Deurwaerd\u00e8re P, Benazzouz A (2011) Noradrenaline and Parkinson\u2019s disease. Front Syst Neurosci 5:31","journal-title":"Front Syst Neurosci"},{"issue":"4","key":"2180_CR19","first-page":"619","volume":"34","author":"YS Ding","year":"1993","unstructured":"Ding YS, Fowler JS, Dewey SL, Logan J, Schlyer DJ, Gatley SJ, Volkow ND, King PT, Wolf AP (1993) Comparison of high specific activity (-) and (+)-6-[18F]fluoronorepinephrine and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. J Nucl Med 34(4):619\u2013629","journal-title":"J Nucl Med"},{"issue":"4","key":"2180_CR20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/syn.10281","volume":"50","author":"YS Ding","year":"2003","unstructured":"Ding YS, Lin KS, Garza V, Carter P, Alexoff D, Logan J, Shea C, Xu Y, King P (2003) Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse 50(4):345\u2013352","journal-title":"Synapse"},{"issue":"2","key":"2180_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1471-4159.2005.03202.x","volume":"94","author":"YS Ding","year":"2005","unstructured":"Ding YS, Lin KS, Logan J, Benveniste H, Carter P (2005) Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S, S) and (R, R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine. J Neurochem 94(2):337\u2013351","journal-title":"J Neurochem"},{"issue":"10","key":"2180_CR22","first-page":"810","volume":"40","author":"LC Dobrowolski","year":"2015","unstructured":"Dobrowolski LC, Eeftinck Schattenkerk DW, Idu MM, van den Born BJ, Verberne HJ (2015) Renal 123I-MIBG scintigraphy before and after kidney autotransplantation. Clin Nulc Med 40(10):810\u2013811","journal-title":"Clin Nulc Med"},{"issue":"1","key":"2180_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13550-018-0360-1","volume":"8","author":"LC Dobrowolski","year":"2018","unstructured":"Dobrowolski LC, Eeftinck Schattenkerk DW, Krediet CTP, Van Brussel PM, Vogt L, Bemelman FJ, Reekers JA, Van Den Born BH, Verberne HJ (2018) Renal sympathetic nerve activity after catheter-based renal denervation. EJNMMI Res 8(1):8. https:\/\/doi.org\/10.1186\/s13550-018-0360-1","journal-title":"EJNMMI Res"},{"issue":"5","key":"2180_CR24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-011-2032-5","volume":"39","author":"O Eskola","year":"2012","unstructured":"Eskola O, Gr\u00f6nroos TJ, Naum A, Marjam\u00e4ki P, Forsback S, Bergman J et al (2012) Novel electrophilic synthesis of 6-[18F]fluorodopamine and comprehensive biological evaluation. Eur J Nucl Med Mol Imaging 39(5):800\u2013810","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2180_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","volume":"63","author":"JA Fallavollita","year":"2014","unstructured":"Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr et al (2014) Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 63:141\u2013149","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2180_CR26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00702-002-0695-6","volume":"109","author":"KF Foley","year":"2002","unstructured":"Foley KF, Van Dort ME, Sievert MK, Ruoho AE, Cozzi NV (2002) Stereospecific inhibition of monoamine uptake transporters by meta-hydroxyephedrine isomers. J Neural Transm (Vienna) 109(10):1229\u20131240","journal-title":"J Neural Transm (Vienna)"},{"key":"2180_CR27","doi-asserted-by":"publisher","DOI":"10.2174\/1874471013666200127122033","author":"V Frantellizzi","year":"2020","unstructured":"Frantellizzi V, Ricci M, Farcomeni A, Pontico M, Pani A, Vincentis G (2020) Usefulness of 5 minutes 123I-mIBG scan in Parkinson's disease and heart failure. Curr Radiopharm. https:\/\/doi.org\/10.2174\/1874471013666200127122033","journal-title":"Curr Radiopharm"},{"issue":"7","key":"2180_CR28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12149-016-1081-z","volume":"30","author":"W Fujita","year":"2016","unstructured":"Fujita W, Matsunari I, Aoki H, Nekolla SG, Kajinami K (2016) Prediction of all-cause death using (11)C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction. Ann Nucl Med 30(7):461\u2013467","journal-title":"Ann Nucl Med"},{"issue":"12","key":"2180_CR29","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2967\/jnumed.113.119966","volume":"54","author":"FC Gaertner","year":"2013","unstructured":"Gaertner FC, Wiedemann T, Yousefi BH, Lee M, Repokis I, Higuchi T et al (2013) Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model. J Nucl Med 54(12):2111\u20132117","journal-title":"J Nucl Med"},{"issue":"1","key":"2180_CR30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroimage.2010.09.040","volume":"56","author":"JD Gallezot","year":"2011","unstructured":"Gallezot JD, Weinzimmer D, Nabulsi N, Lin SF, Fowles K, Sandiego C et al (2011) Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates. Neuroimage 56(1):268\u2013279","journal-title":"Neuroimage"},{"issue":"1","key":"2180_CR31","first-page":"97","volume":"21","author":"PK Garg","year":"1994","unstructured":"Garg PK, Garg S, Zalutsky MR (1994) Synthesis and preliminary evaluation of para- and meta-[18F]fluorobenzylguanidine. Nulc Med Biol 21(1):97\u2013103","journal-title":"Nulc Med Biol"},{"issue":"3","key":"2180_CR32","first-page":"275","volume":"29","author":"B Gasnier","year":"1986","unstructured":"Gasnier B, Roisin MP, Scherman D, Coornaert S, Desplanches G, Henry JP (1986) Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. Mol Pharmacol 29(3):275\u2013280","journal-title":"Mol Pharmacol"},{"key":"2180_CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yhbeh.2018.05.003","volume":"104","author":"PJ Gasser","year":"2018","unstructured":"Gasser PJ, Lowry CA (2018) Organic cation transporter 3: a cellular mechanism underlying rapid, non-genomic glucocorticoid regulation of monoaminergic neurotransmission, physiology, and behavior. Horm Behav 104:173\u2013182","journal-title":"Horm Behav"},{"issue":"2","key":"2180_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/syn.20133","volume":"56","author":"S Ghose","year":"2005","unstructured":"Ghose S, Fujita M, Morrison P, Uhl G, Murphy DL, Mozley PD, Schou M, Halldin C, Innis R (2005) Specific in vitro binding of (S, S)-[3H]MeNER to norepinephrine transporters. Synapse 56(2):100\u2013104","journal-title":"Synapse"},{"issue":"7","key":"2180_CR35","first-page":"1140","volume":"34","author":"JV Glowniak","year":"1993","unstructured":"Glowniak JV, Kilty JE, Amara SG, Hoffman BJ, Turner FE (1993) Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med 34(7):1140\u20131146","journal-title":"J Nucl Med"},{"issue":"1","key":"2180_CR36","first-page":"102","volume":"32","author":"DS Goldstein","year":"1991","unstructured":"Goldstein DS, Chang PC, Smith CB, Herscovitch P, Austin SM, Eisenhofer G, Kopin IJ (1991) Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine. J Nucl Med 32(1):102\u2013110","journal-title":"J Nucl Med"},{"issue":"6","key":"2180_CR37","first-page":"964","volume":"35","author":"DS Goldstein","year":"1994","unstructured":"Goldstein DS, Coronado L, Kopin IJ (1994) 6-[Fluorine-18]fluorodopamine pharmacokinetics and dosimetry in humans. J Nucl Med 35(6):964\u2013973","journal-title":"J Nucl Med"},{"issue":"7","key":"2180_CR38","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/0735-1097(93)90786-Z","volume":"22","author":"DS Goldstein","year":"1993","unstructured":"Goldstein DS, Eisenhofer G, Dunn BB, Armando I, Lenders J, Grossman E et al (1993) Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol 22(7):1961\u20131971","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2180_CR39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10286-008-0464-1","volume":"18","author":"DS Goldstein","year":"2008","unstructured":"Goldstein DS, Eldadah B, Sharabi Y, Axelrod FB (2008) Cardiac sympathetic hypo-innervation in familial dysautonomia. Clin Auton Res 18(3):115\u2013119","journal-title":"Clin Auton Res"},{"key":"2180_CR40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.parkreldis.2017.10.003","volume":"52","author":"DS Goldstein","year":"2018","unstructured":"Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y (2018) Cardiac sympathetic denervation predicts PD in at-risk individuals. Parkinsonism Relat Disord 52:90\u201393","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2180_CR41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02267622","volume":"7","author":"DS Goldstein","year":"1997","unstructured":"Goldstein DS, Holmes C, Stuhlmuller JE, Lenders JW, Kopin IJ (1997) 6-[18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function\u2013studies in normal humans. Clin Auton Res 7(1):17\u201329","journal-title":"Clin Auton Res"},{"issue":"1","key":"2180_CR147","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s002100100426","volume":"365","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Katzper M, Linares O, Kopin IJ (2002) Kinetic model for the fate of 6-[18F]fluorodopamine in the human heart: a novel means to examine cardiac sympathetic neuronal function. Naunyn Schmiedebergs Arch Pharmacol 365(1):38\u201349","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"2180_CR42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1021\/acsmedchemlett.8b00642","volume":"10","author":"F Gourand","year":"2019","unstructured":"Gourand F, Patin D, Henry A, Ibaziz\u00e8ne M, Dhilly M, Fillesoye F et al (2019) Chemical delivery system of MIBG to the central nervous system: synthesis, 11C-radiosynthesis, and in vivo evaluation. ACS Med Chem Lett 10(3):352\u2013357","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"2180_CR43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1210\/jc.2002-021354","volume":"88","author":"L Gourgiotis","year":"2003","unstructured":"Gourgiotis L, Sarlis NJ, Reynolds JC, VanWaes C, Merino MJ, Pacak K (2003) Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab 88(2):637\u2013641","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2180_CR44","first-page":"1342","volume":"40","author":"KH Graefe","year":"1999","unstructured":"Graefe KH, Bossle F, W\u00f6lfel R, Burger A, Souladaki M, Bier D, Dutschka K, Farahati J, B\u00f6nisch H (1999) Sympathomimetic effects of MIBG: comparison with tyramine. J Nucl Med 40(8):1342\u20131351","journal-title":"J Nucl Med"},{"issue":"6\u20137","key":"2180_CR45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuint.2010.03.001","volume":"56","author":"B Guly\u00e1s","year":"2010","unstructured":"Guly\u00e1s B, Brockschnieder D, Nag S, Pavlova E, K\u00e1sa P, Beliczai Z et al (2010) The norepinephrine transporter (NET) radioligand (S, S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study. Neurochem Int 56(6\u20137):789\u2013798","journal-title":"Neurochem Int"},{"issue":"1","key":"2180_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00210-009-0479-8","volume":"381","author":"B Haenisch","year":"2010","unstructured":"Haenisch B, B\u00f6nisch H (2010) Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics. Naunyn Schmiedebergs Arch Pharmacol 381(1):33\u201339","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"2180_CR47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiology.172.3.2772175","volume":"172","author":"MW Hanson","year":"1989","unstructured":"Hanson MW, Feldman JM, Blinder RA, Moore JO, Coleman RE (1989) Carcinoid tumors: iodine-131 MIBG scintigraphy. Radiol 172(3):699\u2013703","journal-title":"Radiol"},{"issue":"7","key":"2180_CR48","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2967\/jnumed.112.104232","volume":"54","author":"T Higuchi","year":"2013","unstructured":"Higuchi T, Yousefi BH, Kaiser F, G\u00e4rtner F, Rischpler C, Reder S et al (2013) Assessment of the 18F-labeled PET tracer LMI1195 for imaging norepinephrine handling in rat hearts. J Nucl Med 54(7):1142\u20131146","journal-title":"J Nucl Med"},{"issue":"10","key":"2180_CR49","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jcmg.2014.11.013","volume":"8","author":"T Higuchi","year":"2015","unstructured":"Higuchi T, Yousefi BH, Reder S, Beschorner M, Laitinen I, Yu M et al (2015) Myocardial kinetics of a novel [(18)F]-labeled sympathetic nerve PET tracer LMI1195 in the isolated perfused rabbit heart. JACC Cardiolvasc Imaging 8(10):1229\u20131231","journal-title":"JACC Cardiolvasc Imaging"},{"key":"2180_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12350-017-1140-4","volume":"2017","author":"Y Hiroshima","year":"2017","unstructured":"Hiroshima Y, Manabe O, Naya M, Tomiyama Y, Magota K, Obara M et al (2017) Quantification of myocardial blood flow with 11C-hydroxyephedrine dynamic PET: comparison with 15O\u2013H2O PET. J Nucl Cardiol 2017:1\u20138. https:\/\/doi.org\/10.1007\/s12350-017-1140-4","journal-title":"J Nucl Cardiol"},{"issue":"11","key":"2180_CR51","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/acschemneuro.5b00202","volume":"6","author":"B Hu","year":"2015","unstructured":"Hu B, V\u0101vere AL, Neumann KD, Shulkin BL, DiMagno SG, Snyder SE (2015) A practical, automated synthesis of meta-[18F]fluorobenzylguanidine for clinical use. ACS Chem Neurosci 6(11):1870\u20131879","journal-title":"ACS Chem Neurosci"},{"key":"2180_CR52","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.metabol.2015.03.001","volume":"64","author":"JJ Hwang","year":"2015","unstructured":"Hwang JJ, Yeckel CW, Gallezot JD, Aguiar RB, Ersahin D, Gao H et al (2015) Imaging human brown adipose tissue under room temperature conditions with (11)C-MRB, a selective norepinephrine transporter PET ligand. Metabolism 64:747\u2013755","journal-title":"Metabolism"},{"issue":"10","key":"2180_CR53","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","volume":"49","author":"I Ilias","year":"2008","unstructured":"Ilias I, Chen CC, Carrasquillo JA, Whatley M, Ling A, Laz\u00farov\u00e1 I et al (2008) Comparison of 6\u201318F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med 49(10):1613\u20131619","journal-title":"J Nucl Med"},{"issue":"9","key":"2180_CR54","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1210\/jc.2003-030235","volume":"88","author":"I Ilias","year":"2003","unstructured":"Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B, Pacak K (2003) Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88(9):4083\u20134087","journal-title":"J Clin Endocrinol Metab"},{"issue":"34","key":"2180_CR55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2152\/jmi.64.205","volume":"64","author":"A Inaki","year":"2017","unstructured":"Inaki A, Yoshimura K, Murayama T, Imai Y, Kuribayashi Y, Higuchi T, Jinguji M, Shiga T, Kinuya S (2017) A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocol. J Med Invest 64(34):205\u2013209","journal-title":"J Med Invest"},{"issue":"2","key":"2180_CR56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.111.184986","volume":"340","author":"S Ito","year":"2012","unstructured":"Ito S, Kusuhara H, Yokochi M, Toyoshima J, Inoue K, Yuasa H, Sugiyama Y (2012) Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. J Pharmacol Exp Ther 340(2):393\u2013403","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"2180_CR57","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1021\/jm400770g","volume":"56","author":"KS Jang","year":"2013","unstructured":"Jang KS, Jung YW, Gu G, Koeppe RA, Sherman PS, Quesada CA, Raffel DM (2013a) 4-[18F]Fluoro-m-hydroxyphenethylguanidine: a radiopharmaceutical for quantifying regional cardiac sympathetic nerve density with positron emission tomography. J Med Chem 56(18):7312\u20137323","journal-title":"J Med Chem"},{"issue":"6","key":"2180_CR58","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.bmcl.2013.01.106","volume":"23","author":"KS Jang","year":"2013","unstructured":"Jang KS, Jung YW, Sherman PS, Quesada CA, Gu G, Raffel DM (2013b) Synthesis and bioevaluation of [(18)F]4-fluoro-m-hydroxyphenethylguanidine ([(18)F]4F-MHPG): a novel radiotracer for quantitative PET studies of cardiac sympathetic innervation. Bioorg Med Chem Lett 23(6):1612\u20131616","journal-title":"Bioorg Med Chem Lett"},{"key":"2180_CR59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jlcr.3791","volume":"62","author":"YW Jung","year":"2019","unstructured":"Jung YW, Gu G, Raffel DM (2019) Improved synthesis of 4-[18F]fluoro-m-hydroxyphenethylguanidine using an iodonium ylide precursor. J Labelled Comp Radiopharm 62:835\u2013842","journal-title":"J Labelled Comp Radiopharm"},{"key":"2180_CR60","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1021\/acschemneuro.7b00051","volume":"8","author":"YW Jung","year":"2017","unstructured":"Jung YW, Jang KS, Gu G, Koeppe RA, Sherman PS, Quesada CA, Raffel DM (2017) [18F]Fluoro-hydroxyphenethylguanidines: efficient synthesis and comparison of two structural isomers as radiotracers of cardiac sympathetic innervation. ACS Chem Neurosci 8:1530\u20131542","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"2180_CR61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-06-0712","volume":"156","author":"P Kaji","year":"2007","unstructured":"Kaji P, Carrasquillo JA, Linehan WM, Chen CC, Eisenhofer G, Pinto PA, Lai EW, Pacak K (2007) The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol 156(4):483\u2013487","journal-title":"Eur J Endocrinol"},{"key":"2180_CR62","doi-asserted-by":"crossref","first-page":"116409","DOI":"10.1016\/j.jns.2019.07.027","volume":"407","author":"M Kawazoe","year":"2019","unstructured":"Kawazoe M, Arima H, Maeda T, Tsuji M, Mishima T, Fujioka S, Tsugawa J, Tsuboi Y (2019) Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease. J Neurol Sci 407:116409","journal-title":"J Neurol Sci"},{"issue":"1","key":"2180_CR63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4254\/wjh.v2.i1.21","volume":"2","author":"YS Kim","year":"2010","unstructured":"Kim YS, Wang F, Liu S (2010) Minimizing liver uptake of cationic Tc radiotracers with ether and crown ether functional groups. World J Hepatol 2(1):21\u201331","journal-title":"World J Hepatol"},{"issue":"9","key":"2180_CR64","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.2011-0333","volume":"96","author":"KS King","year":"2011","unstructured":"King KS, Chen CC, Alexopoulos DK, Whatley MA, Reynolds JC, Patronas N et al (2011) Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-d-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab 96(9):2779\u20132785","journal-title":"J Clin Endocrinol Metab"},{"key":"2180_CR65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nucmedbio.2017.10.005","volume":"56","author":"AK Kirjavainen","year":"2018","unstructured":"Kirjavainen AK, Forsback S, L\u00f3pez-Pic\u00f3n FR, Marjam\u00e4ki P, Takkinen J, Haaparanta-Solin M, Peters D, Solin O (2018) 18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation. Nucl Med Biol 56:39\u201346","journal-title":"Nucl Med Biol"},{"key":"2180_CR66","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1007\/s00259-017-3828-8","volume":"44","author":"R Kobayashi","year":"2017","unstructured":"Kobayashi R, Chen X, Werner RA, Lapa C, Javadi MS, Higuchi T (2017) New horizon in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers. Eur J Nucl Med Mol Imaging 44:2302\u20132309","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"2180_CR67","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.bjc.6601276","volume":"89","author":"L K\u00f6lby","year":"2003","unstructured":"K\u00f6lby L, Bernhardt P, Levin-Jakobsen AM, Johanson V, W\u00e4ngberg B, Ahlman H, Forssell-Aronsson E, Nilsson O (2003) Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters. Br J Cancer 89(7):1383\u20131388","journal-title":"Br J Cancer"},{"key":"2180_CR68","doi-asserted-by":"crossref","first-page":"16186","DOI":"10.3390\/molecules200916186","volume":"20","author":"M Kuchar","year":"2015","unstructured":"Kuchar M, Mamat C (2015) Methods to increase the metabolic stability of 18F-radiotracers. Molecules 20:16186\u201316220","journal-title":"Molecules"},{"issue":"6","key":"2180_CR69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jlcr.3717","volume":"62","author":"S Lahdenpohja","year":"2019","unstructured":"Lahdenpohja S, Keller T, Rajander J, Kirjavainen AK (2019a) Radiosynthesis of the norepinephrine transporter tracer [18F]NS12137 via copper-mediated 18 F-labelling. J Labelled Comp Radiopharm 62(6):259\u2013264","journal-title":"J Labelled Comp Radiopharm"},{"issue":"1","key":"2180_CR70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41181-019-0079-y","volume":"4","author":"SO Lahdenpohja","year":"2019","unstructured":"Lahdenpohja SO, Rajala NA, Rajander J, Kirjavainen AK (2019b) Fast and efficient copper-mediated 18F-fluorination of arylstannanes, aryl boronic acids, and aryl boronic esters without azeotropic drying. EJNMMI Radiopharm Chem 4(1):28","journal-title":"EJNMMI Radiopharm Chem"},{"key":"2180_CR71","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2013.10.004","volume":"86","author":"CS Li","year":"2014","unstructured":"Li CS, Potenza MN, Lee DE, Planeta B, Gallezot JD, Labaree D et al (2014) Decreased norepinephrine transporter availability in obesity: positron emission tomography imaging with (S, S)-[(11)C]O-methylreboxetine. Neuroimage 86:306\u2013310","journal-title":"Neuroimage"},{"key":"2180_CR72","first-page":"1599","volume":"44","author":"ST Li","year":"2003","unstructured":"Li ST, Holmes C, Kopin IJ, Goldstein DS (2003a) Aging-related changes in cardiac sympathetic function in humans, assessed by 6\u201318F-fluorodopamine PET scanning. J Nucl Med 44:1599\u20131603","journal-title":"J Nucl Med"},{"issue":"7","key":"2180_CR73","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0735-1097(00)00626-4","volume":"35","author":"ST Li","year":"2000","unstructured":"Li ST, Tack CJ, Fananapazir L, Goldstein DS (2000) Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 35(7):1867\u20131873","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"2180_CR74","first-page":"1638","volume":"57","author":"X Li","year":"2016","unstructured":"Li X, Dumanic M, Rami-Mark C, Philippe C, Berroter\u00e1n-Infante N, Wadsak W et al (2016) Molecular characterization of cardiac sympathetic denervation and innervation after ischemia-reperfusion injury as assessed by a novel norepinephrine transporter PET tracer [11C]Me@HAPTHI. J Nucl Med 57(Suppl 2):1638","journal-title":"J Nucl Med"},{"issue":"7","key":"2180_CR75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/chir.20055","volume":"16","author":"KS Lin","year":"2004","unstructured":"Lin KS, Ding YS (2004) Synthesis, enantiomeric resolution, and selective C-11 methylation of a highly selective radioligand for imaging the norepinephrine transporter with positron emission tomography. Chirality 16(7):475\u2013481","journal-title":"Chirality"},{"issue":"7","key":"2180_CR76","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.nucmedbio.2012.04.005","volume":"39","author":"SF Lin","year":"2012","unstructured":"Lin SF, Fan X, Yeckel CW, Weinzimmer D, Mulnix T, Gallezot JD, Carson RE, Sherwin RS, Ding YS (2012) Ex vivo and in vivo evaluation of the norepinephrine transporter ligand [11C]MRB for brown adipose tissue imaging. Nucl Med Biol 39(7):1081\u20131086","journal-title":"Nucl Med Biol"},{"issue":"5","key":"2180_CR77","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nucmedbio.2005.04.005","volume":"32","author":"J Logan","year":"2005","unstructured":"Logan J, Ding YS, Lin KS, Pareto D, Fowler J, Biegon A (2005) Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region. Nucl Med Biol 32(5):531\u2013542","journal-title":"Nucl Med Biol"},{"issue":"6","key":"2180_CR78","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.nucmedbio.2007.03.013","volume":"34","author":"J Logan","year":"2007","unstructured":"Logan J, Wang GJ, Telang F, Fowler JS, Alexoff D, Zabroski J et al (2007) Imaging the norepinephrine transporter in humans with (S, S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol 34(6):667\u2013679","journal-title":"Nucl Med Biol"},{"issue":"1","key":"2180_CR79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7150\/thno.29740","volume":"9","author":"FR L\u00f3pez-Pic\u00f3n","year":"2019","unstructured":"L\u00f3pez-Pic\u00f3n FR, Kirjavainen AK, Forsback S, Takkinen JS, Peters D, Haaparanta-Solin M, Solin O (2019) In vivo characterization of a novel norepinephrine transporter PET tracer [18F]NS12137 in adult and immature Sprague-Dawley rats. Theranostics 9(1):11\u201319","journal-title":"Theranostics"},{"issue":"1","key":"2180_CR80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.mnm.0000189780.54658.e8","volume":"27","author":"M Mamede","year":"2006","unstructured":"Mamede M, Carrasquillo JA, Chen CC, Del Corral P, Whatley M, Ilias I, Ayala A, Pacak K (2006) Discordant localization of 2-[18F]-fluoro-2-deoxy-d-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl Med Commun 27(1):31\u201336","journal-title":"Nucl Med Commun"},{"issue":"1","key":"2180_CR81","first-page":"37","volume":"27","author":"TJ Mangner","year":"1986","unstructured":"Mangner TJ, Tobes MC, Wieland DW, Sisson JC, Shapiro B (1986) Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. J Nucl Med 27(1):37\u201344","journal-title":"J Nucl Med"},{"issue":"2","key":"2180_CR82","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nucmedbio.2012.11.009","volume":"40","author":"C Mark","year":"2013","unstructured":"Mark C, Bornatowicz B, Mitterhauser M, Hendl M, Nics L, Haeusler D et al (2013) Development and automation of a novel NET-PET tracer: [11C]Me@APPI. Nucl Med Biol 40(2):295\u2013303","journal-title":"Nucl Med Biol"},{"key":"2180_CR83","first-page":"235","volume":"19","author":"P Melloni","year":"1984","unstructured":"Melloni P, Carniel G, Della Torre A, Bonsignori A, Buonamici M, Pozzi O et al (1984) Potential antidepressant agents. a-aryloxy-benzyl derivatives of ethanolamine and morpholine. Eur J Med Chem 19:235\u2013242","journal-title":"Eur J Med Chem"},{"issue":"16","key":"2180_CR84","first-page":"4342","volume":"51","author":"PG Montaldo","year":"1991","unstructured":"Montaldo PG, Lanciotti M, Casalaro A, Cornaglia-Ferraris P, Ponzoni M (1991) Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms. Cancer Res 51(16):4342\u20134346","journal-title":"Cancer Res"},{"issue":"7","key":"2180_CR85","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2967\/jnumed.116.178913","volume":"58","author":"S Moriguchi","year":"2017","unstructured":"Moriguchi S, Kimura Y, Ichise M, Arakawa R, Takano H, Seki C et al (2017a) PET Quantification of the norepinephrine transporter in human brain with (S, S)-18F-FMeNER-D2. J Nucl Med 58(7):1140\u20131145","journal-title":"J Nucl Med"},{"issue":"12","key":"2180_CR86","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/ijnp\/pyx069","volume":"20","author":"S Moriguchi","year":"2017","unstructured":"Moriguchi S, Takano H, Kimura Y, Nagashima T, Takahata K, Kubota M et al (2017b) Occupancy of norepinephrine transporter by duloxetine in human brains measured by positron emission tomography with (S, S)-[18F]FMeNER-D2. Int J Neuropsychopharmacol 20(12):957\u2013962","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"2180_CR87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/appi.ajp.2016.15101334","volume":"174","author":"S Moriguchi","year":"2017","unstructured":"Moriguchi S, Yamada M, Takano H, Nagashima T, Takahata K, Yokokawa K et al (2017c) Norepinephrine transporter in major depressive disorder: A PET study. Am J Psychiatry 174(1):36\u201341","journal-title":"Am J Psychiatry"},{"issue":"5","key":"2180_CR88","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2967\/jnumed.116.180992","volume":"58","author":"O Muzik","year":"2017","unstructured":"Muzik O, Mangner TJ, Leonard WR, Kumar A, Granneman JG (2017) Sympathetic innervation of cold-activated brown and white fat in lean young adults. J Nucl Med 58(5):799\u2013806","journal-title":"J Nucl Med"},{"key":"2180_CR89","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2017.04.026","volume":"377","author":"Y Niimi","year":"2017","unstructured":"Niimi Y, Ito S, Murate K, Hirota S, Hikichi C, Ishikawa T et al (2017) Usefulness of combining 123I-FP-CIT-SPECT striatal asymmetry index and cardiac 123I-metaiodobenzylguanidine scintigraphy examinations for diagnosis of parkinsonisms. J Neurol Sci 377:174\u2013178","journal-title":"J Neurol Sci"},{"issue":"5","key":"2180_CR90","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1017\/S1461145712001009","volume":"16","author":"T Nogami","year":"2013","unstructured":"Nogami T, Takano H, Arakawa R, Ichimiya T, Fujiwara H, Kimura Y et al (2013) Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S, S)-[(18)F]FMeNER-D(2). Int J Neuropsychopharmacol 16(5):937\u2013943","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"2180_CR91","first-page":"60","volume":"21","author":"S Nuvoli","year":"2018","unstructured":"Nuvoli S, Palumbo B, Malaspina S, Madeddu G, Spanu A (2018) 123I-ioflupane SPET and 123I-MIBG in the diagnosis of Parkinson's disease and parkinsonian disorders and in the differential diagnosis between Alzheimer's and Lewy's bodies dementias. Hell J Nucl Med 21(1):60\u201368","journal-title":"Hell J Nucl Med"},{"issue":"10","key":"2180_CR92","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1017\/S1461145713000680","volume":"16","author":"S Nyberg","year":"2013","unstructured":"Nyberg S, Jucaite A, Takano A, K\u00e5gedal M, Csel\u00e9nyi Z, Halldin C, Farde L (2013) Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR. Int J Neuropsychopharmacol 16(10):2235\u20132244","journal-title":"Int J Neuropsychopharmacol"},{"issue":"11","key":"2180_CR93","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/MNM.0000000000000898","volume":"39","author":"Y Okada","year":"2018","unstructured":"Okada Y, Shiraishi M, Nakamura H, Maki F, Sasaki N, Hasegawa Y, Sasaki O, Nakashima Y (2018) Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease. Nucl Med Commun 39(11):983\u2013988","journal-title":"Nucl Med Commun"},{"issue":"3","key":"2180_CR94","first-page":"1305","volume":"283","author":"MJ Owens","year":"1997","unstructured":"Owens MJ, Morgan WN et al (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283(3):1305\u20131322","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2180_CR95","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.HYP.38.1.6","volume":"38","author":"K Pacak","year":"2001","unstructured":"Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS (2001) 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38(1):6\u20138","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"2180_CR96","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.2967\/jnumed.116.186833","volume":"58","author":"N Pandit-Taskar","year":"2017","unstructured":"Pandit-Taskar N, Modak S (2017) Norepinephrine Transporter as a Target for Imaging and Therapy. J Nucl Med 58(Suppl 2):39S\u201353S","journal-title":"J Nucl Med"},{"issue":"1","key":"2180_CR97","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2967\/jnumed.117.193169","volume":"59","author":"N Pandit-Taskar","year":"2018","unstructured":"Pandit-Taskar N, Zanzonico P, Staton KD et al (2018) Biodistribution and dosimetry of 18F-meta-fluorobenzylguanidine: a first-in-human PET\/CT imaging study of patients with neuroendocrine malignancies. J Nucl Med 59(1):147\u2013153","journal-title":"J Nucl Med"},{"issue":"2","key":"2180_CR98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.semnuclmed.2016.10.007","volume":"47","author":"T Pfluger","year":"2017","unstructured":"Pfluger T, Piccardo A (2017) Neuroblastoma: MIBG imaging and new tracers. Semin Nucl Med 47(2):143\u2013157","journal-title":"Semin Nucl Med"},{"key":"2180_CR99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002590000449","volume":"28","author":"M Pietil\u00e4","year":"2001","unstructured":"Pietil\u00e4 M, Malminiemi K, Ukkonen H, Saraste M, N\u00e5gren K, Lehikoinen P et al (2001) Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med 28:373\u2013376","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"2180_CR148","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2967\/jnumed.118.217463","volume":"60","author":"DA Pryma","year":"2019","unstructured":"Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L et al (2019) Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. J Nucl Med 60(5):623\u2013630","journal-title":"J Nucl Med"},{"key":"2180_CR100","unstructured":"Purohit A, Harris TD, Radeke HS, Robinson SP, Yu M, Casebier DS (2008) Ligands for imaging cardiac innervation. Patent WO\/2008\/083056"},{"issue":"3","key":"2180_CR101","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nucmedbio.2012.11.014","volume":"40","author":"DM Raffel","year":"2013","unstructured":"Raffel DM, Chen W, Jung YW, Jang KS, Gu G, Cozzi NV (2013a) Radiotracers for cardiac sympathetic innervation: transport kinetics and binding affinities for the human norepinephrine transporter. Nucl Med Biol 40(3):331\u2013337","journal-title":"Nucl Med Biol"},{"issue":"Suppl 1","key":"2180_CR102","first-page":"96","volume":"58","author":"DM Raffel","year":"2017","unstructured":"Raffel DM, Crawford T, Jung YW, Koeppe R, Gu G, Rothley J, Frey K (2017) Quantifying cardiac sympathetic nerve density using 18F-hydroxyphenethylguanidines: pilot studies in heart failure patients staged for implantable cardioverter defibrillator placement. J Nucl Med 58(Suppl 1):96","journal-title":"J Nucl Med"},{"issue":"9","key":"2180_CR103","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1021\/jm061398y","volume":"50","author":"DM Raffel","year":"2007","unstructured":"Raffel DM, Jung YW, Gildersleeve DL, Sherman PS, Moskwa JJ, Tluczek LJ, Chen W (2007) Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors. J Med Chem 50(9):2078\u20132088","journal-title":"J Med Chem"},{"key":"2180_CR104","doi-asserted-by":"crossref","first-page":"e007965","DOI":"10.1161\/CIRCIMAGING.118.007965","volume":"11","author":"DM Raffel","year":"2018","unstructured":"Raffel DM, Jung YW, Koeppe RA, Jang KS, Gu G, Scott PJH, Murthy VL, Rothley J, Frey KA (2018) First-in-human studies of [18F]fluorohydroxyphenethylguanidines. Circ Cardiovasc Imaging 11:e007965","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"2180_CR105","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2967\/jnumed.113.120659","volume":"54","author":"DM Raffel","year":"2013","unstructured":"Raffel DM, Koeppe RA, Jung YW, Gu G, Jang KS, Sherman PS, Quesada CA (2013b) Quantification of cardiac sympathetic nerve density with N-11C-guanyl-meta-octopamine and tracer kinetic analysis. J Nucl Med 54(9):1645\u20131652","journal-title":"J Nucl Med"},{"issue":"1","key":"2180_CR106","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13550-015-0113-3","volume":"5","author":"C Rami-Mark","year":"2015","unstructured":"Rami-Mark C, Berroter\u00e1n-Infante N, Philippe C, Foltin S, Vraka C, Hoepping A et al (2015) Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI. EJNMMI Res 5(1):113","journal-title":"EJNMMI Res"},{"issue":"8","key":"2180_CR107","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nucmedbio.2016.05.004","volume":"43","author":"C Rami-Mark","year":"2016","unstructured":"Rami-Mark C, Eberherr N, Berroter\u00e1n-Infante N, Vanicek T, Nics L, Lanzenberger R et al (2016) [(18)F]FMeNER-D2: a systematic in vitro analysis of radio-metabolism. Nucl Med Biol 43(8):490\u2013495","journal-title":"Nucl Med Biol"},{"issue":"8","key":"2180_CR108","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.nucmedbio.2013.08.007","volume":"40","author":"C Rami-Mark","year":"2013","unstructured":"Rami-Mark C, Zhang MR, Mitterhauser M, Lanzenberger R, Hacker M, Wadsak W (2013) [18F]FMeNER-D2: reliable fully-automated synthesis for visualization of the norepinephrine transporter. Nucl Med Biol 40(8):1049\u20131054","journal-title":"Nucl Med Biol"},{"issue":"7","key":"2180_CR109","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00259-013-2393-z","volume":"40","author":"C Rischpler","year":"2013","unstructured":"Rischpler C, Fukushima K, Isoda T, Javadi MS, Dannals RF, Abraham R, Wahl R, Bengel FM, Higuchi T (2013) Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts. Eur J Nucl Med Mol Imaging 40(7):1077\u20131083","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2180_CR110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vascn.2010.05.001","volume":"63","author":"HN Saihkay","year":"2011","unstructured":"Saihkay HN, Rickards KJ, Page CP, Ballinger JR (2011) Validating 123I-metaiodobenzylguanidine as a platelet marker for non-invasive imaging in rabbits. J Pharmacol Toxicol Methods 63(1):69\u201378","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2180_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-019-0471-4","author":"E Sanchez-Rangel","year":"2019","unstructured":"Sanchez-Rangel E, Gallezot JD, Yeckel CW, Lam W, Belfort-DeAguiar R, Chen MK, Carson RE, Sherwin R, Hwang JJ (2019) Norepinephrine transporter availability in brown fat is reduced in obesity: a human PET study with [11C] MRB. Int J Obes (Lond). https:\/\/doi.org\/10.1038\/s41366-019-0471-4","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"2180_CR112","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.euroneuro.2005.01.007","volume":"15","author":"M Schou","year":"2005","unstructured":"Schou M, Halldin C, Pike VW, Mozley PD, Dobson D et al (2005) Post-mortem human brain autoradiography of the norepinephrine transporter using (S, S)-[18F]FMeNER-D2. Eur Neuropsychopharmacol 15(5):517\u2013520","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"2180_CR113","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/syn.20031","volume":"53","author":"M Schou","year":"2004","unstructured":"Schou M, Halldin C, S\u00f3v\u00e1g\u00f3 J, Pike VW, Hall H, Guly\u00e1s B et al (2004) PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 53(2):57\u201367","journal-title":"Synapse"},{"issue":"11","key":"2180_CR114","doi-asserted-by":"crossref","first-page":"H1273","DOI":"10.1152\/ajpheart.00492.2012","volume":"303","author":"C Schroeder","year":"2012","unstructured":"Schroeder C, Jordan J (2012) Norepinephrine transporter function and human cardiovascular disease. Am J Physiol Heart Circ Physiol 303(11):H1273\u2013H1282","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"2180_CR115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-010-1824-9","volume":"210","author":"M Sekine","year":"2010","unstructured":"Sekine M, Arakawa R, Ito H, Okumura M, Sasaki T, Takahashi H et al (2010) Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S, S)-[18F]FMeNER-D2. Psychopharmacology 210(3):331\u2013336","journal-title":"Psychopharmacology"},{"issue":"5","key":"2180_CR116","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00259-006-0312-2","volume":"34","author":"AJ Severance","year":"2007","unstructured":"Severance AJ, Milak MS, Kumar JSD, Prabhakaran J, Majo VJ, Simpson NR et al (2007) In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter. Eur J Nucl Med Mol Imaging 34(5):688\u2013693","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2180_CR117","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hbm.23071","volume":"37","author":"HL Sigurdardottir","year":"2016","unstructured":"Sigurdardottir HL, Kranz GS, Rami-Mark C, James GM, Vanicek T, Gryglewski G et al (2016) Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET. Hum Brain Mapp 37(3):884\u2013895","journal-title":"Hum Brain Mapp"},{"key":"2180_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0461-x","author":"HL Sigurdardottir","year":"2019","unstructured":"Sigurdardottir HL, Kranz GS, Rami-Mark C, James GM, Vanicek T, Gryglewski G et al (2019) Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-019-0461-x","journal-title":"Mol Psychiatry"},{"issue":"9","key":"2180_CR119","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2967\/jnumed.114.140137","volume":"55","author":"AJ Sinusas","year":"2014","unstructured":"Sinusas AJ, Lazewatsky J, Brunetti J, Heller G, Srivastava A, Liu YH et al (2014) Biodistribution and radiation dosimetry of LMI1195: first-in-human study of a novel 18F-labeled tracer for imaging myocardial innervation. J Nucl Med 55(9):1445\u20131451","journal-title":"J Nucl Med"},{"key":"2180_CR120","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fneur.2019.00152","volume":"10","author":"C Skowronek","year":"2019","unstructured":"Skowronek C, Zange L, Lipp A (2019) Cardiac 123I-MIBG scintigraphy in neurodegenerative Parkinson syndromes: performance and pitfalls in clinical practice. Front Neurol 10:152. https:\/\/doi.org\/10.3389\/fneur.2019.00152","journal-title":"Front Neurol"},{"issue":"4","key":"2180_CR121","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FJC.0b013e3182270783","volume":"58","author":"TF Solbach","year":"2011","unstructured":"Solbach TF, Grube M, Fromm MF, Zolk O (2011) Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization. J Cardiovasc Pharmacol 58(4):409\u2013417","journal-title":"J Cardiovasc Pharmacol"},{"issue":"12","key":"2180_CR122","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2337\/diabetes.51.12.3545","volume":"51","author":"CJ Tack","year":"2002","unstructured":"Tack CJ, van Gurp PJ, Holmes C, Goldstein DS (2002) Local sympathetic denervation in painful diabetic neuropathy. Diabetes 51(12):3545\u20133553","journal-title":"Diabetes"},{"issue":"11","key":"2180_CR123","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00259-009-1194-x","volume":"36","author":"A Takano","year":"2009","unstructured":"Takano A, Guly\u00e1s B, Varrone A, Halldin C (2009) Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S, S)-[18F]FMeNER-D2 and (S, S)-[11C]MeNER. Eur J Nucl Med Mol Imaging 36(11):1885\u20131891","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2180_CR124","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00259-007-0598-8","volume":"35","author":"A Takano","year":"2008","unstructured":"Takano A, Guly\u00e1s B, Varrone A, Karlsson P, Schou M, Airaksinen AJ et al (2008a) Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S, S)-[18F]FMeNER-D2. Eur J Nucl Med Mol Imaging 35(1):153\u2013157","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2180_CR125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00213-012-2901-z","volume":"226","author":"A Takano","year":"2013","unstructured":"Takano A, Halldin C, Farde L (2013) SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study. Psychopharmacology 226(1):147\u2013153","journal-title":"Psychopharmacology"},{"issue":"3","key":"2180_CR126","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00259-007-0622-z","volume":"35","author":"A Takano","year":"2008","unstructured":"Takano A, Halldin C, Varrone A, Karlsson P, Sj\u00f6holm N, Stubbs JB et al (2008b) Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S, S)-[18F]FMeNER-D2: a human whole-body PET study. Eur J Nucl Med Mol Imaging 35(3):630\u2013636","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2180_CR127","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-011-2212-9","volume":"216","author":"A Takano","year":"2011","unstructured":"Takano A, Nag S, Guly\u00e1s B, Halldin C, Farde L (2011) NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo. Psychopharmacology 216(2):279\u2013286","journal-title":"Psychopharmacology"},{"issue":"2","key":"2180_CR128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuroimage.2008.05.040","volume":"42","author":"A Takano","year":"2008","unstructured":"Takano A, Varrone A, Guly\u00e1s B, Karlsson P, Tauscher J, Halldin C (2008c) Mapping of the norepinephrine transporter in the human brain using PET with (S, S)-[18F]FMeNER-D2. Neuroimage 42(2):474\u2013482","journal-title":"Neuroimage"},{"issue":"4","key":"2180_CR129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/S1461145713001521","volume":"17","author":"H Takano","year":"2014","unstructured":"Takano H, Arakawa R, Nogami T, Suzuki M, Nagashima T, Fujiwara H et al (2014) Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S, S)-[18F]FMeNER-D2. Int J Neuropsychopharmacol 17(4):553\u2013560","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2\u20133","key":"2180_CR130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","volume":"340","author":"M Tatsumi","year":"1997","unstructured":"Tatsumi M, Groshan K et al (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340(2\u20133):249\u2013258","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"2180_CR131","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2967\/jnumed.107.043281","volume":"48","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Carrasquillo JA, Whatley M, Eisenhofer G, Chen CC, Ling A et al (2007) Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6\u201318F-fluorodopamine PET. J Nucl Med 48(12):1940\u20131944","journal-title":"J Nucl Med"},{"issue":"12","key":"2180_CR132","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B et al (2009a) Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94(12):4757\u20134767","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2180_CR133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2265.2008.03496.x","volume":"71","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Ling A, Adams KT, Pacak K (2009b) Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO). Clin Endocrinol (Oxf) 71(1):11\u201317","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2180_CR134","first-page":"1775","volume":"46","author":"DN Tipre","year":"2005","unstructured":"Tipre DN, Goldstein DS (2005) Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med 46(11):1775\u20131781","journal-title":"J Nucl Med"},{"issue":"4","key":"2180_CR135","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s12350-017-1132-4","volume":"26","author":"Y Tokuda","year":"2019","unstructured":"Tokuda Y, Sakakibara M, Yoshinaga K, Yamada S, Kamiya K, Asakawa N et al (2019) Early therapeutic effects of adaptive servo-ventilation on cardiac sympathetic nervous function in patients with heart failure evaluated using a combination of 11C-HED PET and 123I-MIBG SPECT. J Nucl Cardiol 26(4):1079\u20131089","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"2180_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-017-0817-2","volume":"19","author":"MI Travin","year":"2017","unstructured":"Travin MI (2017) Current Clinical Applications and Next Steps for Cardiac Innervation Imaging. Curr Cardiol Rep 19(1):1. https:\/\/doi.org\/10.1007\/s11886-017-0817-2","journal-title":"Curr Cardiol Rep"},{"key":"2180_CR137","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01629-8","author":"MI Travin","year":"2019","unstructured":"Travin MI (2019) Expanding the clinical potential of cardiac radionuclide adrenergic imaging. J Nucl Cardiol. https:\/\/doi.org\/10.1007\/s12350-019-01629-8","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"2180_CR138","first-page":"969","volume":"36","author":"S Tsuchimochi","year":"1995","unstructured":"Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, Konishi J (1995) Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 36(6):969\u2013974","journal-title":"J Nucl Med"},{"issue":"1","key":"2180_CR139","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41398-019-0619-y","volume":"9","author":"C Ulke","year":"2019","unstructured":"Ulke C, Rullmann M, Huang J, Luthardt J, Becker GA, Patt M et al (2019) Adult attention-deficit\/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S, S)-O-[11C]methylreboxetine positron emission tomography study. Transl Psychiatry 9(1):301","journal-title":"Transl Psychiatry"},{"issue":"9","key":"2180_CR140","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00006231-200409000-00013","volume":"25","author":"G Vaidyanathan","year":"2004","unstructured":"Vaidyanathan G, Affleck DJ, Alston KL, Welsh P, Zalutsky MR (2004) Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells. Nucl Med Commun 25(9):947\u2013955","journal-title":"Nucl Med Commun"},{"key":"2180_CR141","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1021\/jm00047a022","volume":"37","author":"G Vaidyanathan","year":"1994","unstructured":"Vaidyanathan G, Affleck DJ, Zalutsky MR (1994) (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography. J Med Chem 37:3655\u20133662","journal-title":"J Med Chem"},{"key":"2180_CR142","first-page":"644","volume":"36","author":"G Vaidyanathan","year":"1995","unstructured":"Vaidyanathan G, Affleck DJ, Zalutsky MR (1995) Validation of 4-[18F]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG. J Nucl Med 36:644\u2013650","journal-title":"J Nucl Med"},{"issue":"1","key":"2180_CR143","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/bc950078i","volume":"7","author":"G Vaidyanathan","year":"1996","unstructured":"Vaidyanathan G, Affleck DJ, Zalutsky MR (1996) No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine. Bioconjug Chem 7(1):102\u2013107","journal-title":"Bioconjug Chem"},{"issue":"8","key":"2180_CR144","first-page":"673","volume":"42","author":"G Vaidyanathan","year":"2015","unstructured":"Vaidyanathan G, McDouglad D, Koumarianou E, Choi J, Hens M, Zalutsky MR (2015) Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): a novel 18F-labeled analogue of MIBG. Nulc Med Biol 42(8):673\u2013684","journal-title":"Nulc Med Biol"},{"issue":"2","key":"2180_CR145","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/bjc.1997.366","volume":"76","author":"G Vaidyanathan","year":"1997","unstructured":"Vaidyanathan G, Zhao XG, Larsen RH, Zalutsky MR (1997a) 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. Br J Cancer 76(2):226\u2013233","journal-title":"Br J Cancer"},{"issue":"2","key":"2180_CR146","first-page":"330","volume":"38","author":"G Vaidyanathan","year":"1997","unstructured":"Vaidyanathan G, Zhao XG, Strickland DK, Zalutsky MR (1997b) No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog. J Nucl Med 38(2):330\u2013334","journal-title":"J Nucl Med"},{"key":"2180_CR149","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/(SICI)1099-1344(200005)43:6<603::AID-JLCR345>3.0.CO;2-#","volume":"43","author":"ME Van Dort","year":"2000","unstructured":"Van Dort ME, Tluczek L (2000) Synthesis and carbon-11 labeling of the stereoisomers of meta-hydroxyephedrine (HED) and meta-hydroxyseudoephedrine (HPED). J Labelled Comp Radiopharm 43:603\u2013612","journal-title":"J Labelled Comp Radiopharm"},{"issue":"12","key":"2180_CR150","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamapsychiatry.2014.1226","volume":"71","author":"T Vanicek","year":"2014","unstructured":"Vanicek T, Spies M, Rami-Mark C, Savli M, H\u00f6flich A, Kranz GS et al (2014) The norepinephrine transporter in attention-deficit\/hyperactivity disorder investigated with positron emission tomography. JAMA Psychiatry 71(12):1340\u20131349","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"2180_CR151","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.nucmedbio.2014.06.004","volume":"41","author":"KH Vase","year":"2014","unstructured":"Vase KH, Peters D, Nielsen E\u00d8, Alstrup AK, Bender D (2014) [11C]NS8880, a promising PET radiotracer targeting the norepinephrine transporter. Nucl Med Biol 41(9):758\u2013764","journal-title":"Nucl Med Biol"},{"issue":"14","key":"2180_CR152","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jlcr.3685","volume":"61","author":"AL V\u0101vere","year":"2018","unstructured":"V\u0101vere AL, Neumann KD, Butch ER, Hu B, DiMagno SG, Snyder SE (2018) Improved, one-pot synthesis of 6-[18 F]fluorodopamine and quality control testing for use in patients with neuroblastoma. J Labelled Comp Radiopharm 61(14):1069\u20131080","journal-title":"J Labelled Comp Radiopharm"},{"issue":"9","key":"2180_CR153","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00259-018-4002-7","volume":"45","author":"FJ Vettermann","year":"2018","unstructured":"Vettermann FJ, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M et al (2018) Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults. Eur J Nucl Med Mol Imaging 45(9):1618\u20131625","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2180_CR154","doi-asserted-by":"crossref","first-page":"pii:E847","DOI":"10.3390\/cancers11060847","volume":"11","author":"AR Vyakaranam","year":"2019","unstructured":"Vyakaranam AR, Crona J, Norl\u00e9n O, Hellman P, Sundin A (2019) 11C-hydroxy-ephedrine-PET\/CT in the diagnosis of pheochromocytoma and paraganglioma. Cancers (Basel) 11(6):pii:E847","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2180_CR155","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13550-018-0421-5","volume":"8","author":"T Wang","year":"2018","unstructured":"Wang T, Wu KY, Miner RC, Renaud JM, Beanlands RSB, deKemp RA (2018) Reproducible quantification of cardiac sympathetic innervation using graphical modeling of carbon-11-meta-hydroxyephedrine kinetics with dynamic PET-CT imaging. EJNMMI Res 8(1):63. https:\/\/doi.org\/10.1186\/s13550-018-0421-5","journal-title":"EJNMMI Res"},{"key":"2180_CR156","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2967\/jnumed.115.158493","volume":"56","author":"RA Werner","year":"2015","unstructured":"Werner RA, Rischpler C, Onthank D, Lapa C, Robinson S, Samnick S, Javadi M, Schwaiger M, Nekolla SG, Higuchi T (2015) Retention kinetics of the 18F-labeled sympathetic nerve PET tracer LMI1195: Comparison with 11C-hydroxyephedrine and 123I-MIBG. J Nucl Med 56:1429\u20131433","journal-title":"J Nucl Med"},{"issue":"2","key":"2180_CR157","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00259-015-3171-x","volume":"43","author":"RA Werner","year":"2016","unstructured":"Werner RA, Maya Y, Rischpler C, Javadi MS, Fukushima K, Lapa C, Herrmann K, Higuchi T (2016) Sympathetic nerve damage and restoration after ischemia-reperfusion injury as assessed by (11)C-hydroxyephedrine. Eur J Nucl Med Mol Imaging 43(2):312\u2013318","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2180_CR158","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1038\/s41598-018-29509-0","volume":"8","author":"RA Werner","year":"2018","unstructured":"Werner RA, Chen X, Maya Y, Eissler C, Hirano M, Nose N, Wakabayashi H, Lapa C, Javadi MS, Higuchi T (2018) The impact of ageing on 11-Chydroxyephedrine uptake in the rat heart. Sci Rep 8:11120","journal-title":"Sci Rep"},{"issue":"1","key":"2180_CR0159","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/s41598-019-53596-2","volume":"9","author":"RA Werner","year":"2019","unstructured":"Werner RA, Wakabayashi H, Chen X, Hayakawa N, Lapa C, Rowe SP, Javadi MS, Robinson S, Higuchi T (2019) Ventricular distribution pattern of the novel sympathetic nerve PET radiotracer 18F-LMI1195 in rabbit hearts. Sci Rep 9(1):17026","journal-title":"Sci Rep"},{"issue":"2","key":"2180_CR159","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2967\/jnumed.116.176891","volume":"58","author":"KK Wong","year":"2017","unstructured":"Wong KK, Raffel DM, Bohnen NI, Altinok G, Gilman S, Frey KA (2017) 2-Year natural decline of cardiac sympathetic innervation in idiopathic Parkinson Disease studied with 11C-hydroxyephedrine PET. J Nucl Med 58(2):326\u2013331","journal-title":"J Nucl Med"},{"issue":"49","key":"2180_CR160","doi-asserted-by":"crossref","first-page":"32776","DOI":"10.1074\/jbc.273.49.32776","volume":"273","author":"X Wu","year":"1998","unstructured":"Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273(49):32776\u201332786","journal-title":"J Biol Chem"},{"key":"2180_CR161","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04629-5","author":"KY Wu","year":"2019","unstructured":"Wu KY, Zelt JGE, Wang T, Dinculescu V, Miner R, Lapierre C et al (2019) Reliable quantification of myocardial sympathetic innervation and regional denervation using [11C]meta-hydroxyephedrine PET. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-019-04629-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2180_CR162","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2967\/jnumed.117.201525","volume":"59","author":"A Yamaguchi","year":"2018","unstructured":"Yamaguchi A, Hanaoka H, Higuchi T, Tsushima Y (2018) Radiolabeled (4-fluoro-3-iodobenzyl)guanidine improves imaging and targeted radionuclide therapy of norepinephrine transporter-expressing tumors. J Nucl Med 59(5):815\u2013821","journal-title":"J Nucl Med"},{"issue":"4","key":"2180_CR163","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/CIRCIMAGING.110.962126","volume":"4","author":"M Yu","year":"2011","unstructured":"Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M et al (2011) Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging 4(4):435\u2013443","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"2180_CR164","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s00259-012-2204-y","volume":"39","author":"M Yu","year":"2012","unstructured":"Yu M, Bozek J, Lamoy M, Kagan M, Benites P, Onthank D, Robinson SP (2012) LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment. Eur J Nucl Med Mol Imaging 39(12):1910\u20131919","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2180_CR165","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nucmedbio.2013.03.003","volume":"40","author":"M Yu","year":"2013","unstructured":"Yu M, Bozek J, Kagan M, Guaraldi M, Silva P, Azure M, Onthank D, Robinson SP (2013) Cardiac retention of PET neuronal imaging agent LMI1195 in different species: impact of norepinephrine uptake-1 and -2 transporters. Nucl Med Biol 40(5):682\u2013688","journal-title":"Nucl Med Biol"},{"key":"2180_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(18)32023-0","author":"J Zelt","year":"2018","unstructured":"Zelt J, Renaud J, Mielniczuk L, Garrard L, Walter O, Guo A, deKamp R, Beanlands R (2018) Fluorine-18 LMI1195 positron emission tomography provides accurate measure of cardiac sympathetic innervation compared to carbon-11 hydroxyephedrine. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/s0735-1097(18)32023-0","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2180_CR167","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00259-013-2558-9","volume":"41","author":"H Zhang","year":"2014","unstructured":"Zhang H, Huang R, Pillarsetty N, Thorek DL, Vaidyanathan G, Serganova I, Blasberg RG, Lewis JS (2014a) Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter. Eur J Nucl Med Mol Imaging 41(2):322\u2013332","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"2180_CR168","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1158\/1078-0432.CCR-13-1153","volume":"20","author":"H Zhang","year":"2014","unstructured":"Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG (2014b) Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clin Cancer Res 20(8):2182\u20132191","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2180_CR169","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/open.201500056","volume":"4","author":"BD Zlatopolskiy","year":"2015","unstructured":"Zlatopolskiy BD, Zischler J, Urusova EA, Endepols H, Kordys E, Frauendorf H, Mottaghy FM, Neumaier B (2015) A practical one-pot synthesis of positron emission tomography (PET) tracers via Nickel-mediated radiofluorination. ChemistryOpen 4(4):457\u2013462","journal-title":"ChemistryOpen"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-020-02180-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T23:32:18Z","timestamp":1617924738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-020-02180-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1007\/s00702-020-02180-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}